Suchergebnisse - "Semenzato, Laura"

PubPharm (9)

1

N-nitrosodimethylamine-Contaminated Valsartan and Risk of Cancer : A Nationwide Study of 1.4 Million Valsartan Users

enthalten in: Journal of the American Heart Association | 2022

von Mansouri, I. | Botton, J. | Semenzato, L. | +2

2

Does Measles, Mumps, and Rubella (MMR) Vaccination Protect against COVID-19 Outcomes : A Nationwide Cohort Study

enthalten in: Vaccines | 2022

von Kolla, E. | Weill, A. | Desplas, D. | +3

3

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule : A cohort study of 28 million people in France

enthalten in: The Lancet regional health. Europe | 2022

von Semenzato, L. | Botton, J. | Drouin, J. | +8

4

Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID-19 : A Nationwide Matched Population-Based Cohort Study

enthalten in: Journal of the American Heart Association | 2022

von Bouillon, K. | Baricault, B. | Semenzato, L. | +6

5

No association of low-dose aspirin with severe COVID-19 in France : A cohort of 31.1 million people without cardiovascular disease

enthalten in: Research and practice in thrombosis and haemostasis | 2022

von Botton, J. | Semenzato, L. | Dupouy, J. | +4

6

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations

enthalten in: JAMA network open | 2022

von Botton, J. | Semenzato, L. | Jabagi, M. | +4

7

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting : cohort study

enthalten in: BMJ medicine | 2022

von Bouillon, K. | Baricault, B. | Botton, J. | +8

8

Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories : A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System

enthalten in: PloS one | 2022

von Semenzato, L. | Botton, J. | Baricault, B. | +6

9

No association of low‐dose aspirin with severe COVID‐19 in France : A cohort of 31.1 million people without cardiovascular disease

enthalten in: Research and Practice in Thrombosis and Haemostasis | 2022

von Botton, J. | Semenzato, L. | Dupouy, J. | +4

1
[1]